Subsidiary of Beijing Strong Biotechnologies, Inc. (300406.SZ) obtains multiple medical device registration certificates.

15:57 31/03/2026

Jiuqiang Biological (300406.SZ) announced that its wholly-owned subsidiary, Fuzhou Maixin Biotechnology Development Co., Ltd., recently received the "Medical Device Registration Certificate" issued by the National Medical Products Administration. The product names are: HER2 Antibody Reagent (Immunohistochemistry), Progesterone Receptor Antibody Reagent (Immunohistochemistry), and CD20 Antibody Reagent (Immunohistochemistry).

Announcement from Beijing Strong Biotechnologies, Inc. (300406.SZ): The company's wholly-owned subsidiary, Fuzhou Mainew Biotechnology Development Co., Ltd., recently received the "Medical Device Registration Certificate" issued by the National Medical Products Administration. The products include: HER2 antibody reagent (immunohistochemistry method), progesterone receptor antibody reagent (immunohistochemistry method), CD20 antibody reagent (immunohistochemistry method).

SUNAC SERVICES (01516) spent 836,000 Hong Kong dollars to repurchase 1 million shares on March 31st.

YONGDA AUTO (03669) expects steady improvement in operating cash flow in 2025. The new energy business segment is expected to grow rapidly.

Shandong Linuo Pharmaceutical Packaging (301188.SZ) shareholder Linuo Investment Holdings Group plans to transfer 8 million shares through inquiry.

SUNAC SERVICES (01516) spent 836,000 Hong Kong dollars to repurchase 1 million shares on March 31st.

YONGDA AUTO (03669) expects steady improvement in operating cash flow in 2025. The new energy business segment is expected to grow rapidly.

Shandong Linuo Pharmaceutical Packaging (301188.SZ) shareholder Linuo Investment Holdings Group plans to transfer 8 million shares through inquiry.